Direct sponsor and CRO relationships, supported by experience in commercial research infrastructure.

Central study management, recruitment monitoring and consistent communication with sponsors and CROs.

Electronic searches, disease registers and coded clinical data support rapid, protocol-specific cohort estimates.

In-person, telephone, remote, decentralised and hybrid delivery options, depending on protocol requirements.

Trusted primary-care relationships support access to patients who may not attend hospital research centres.

Suitable for Phase II–IV, pragmatic, observational, post-authorisation and real-world studies.